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Abstract
Background: Sarcopenic obesity refers to age-related loss of skeletal muscle mass and function, in the face of
obesity. We aimed to examine the association of falls with sarcopenic obesity and its components, among elderly
individuals in the population.
Methods: Participants were 353 men and 245 women aged 65-98 yr of the Geelong Osteoporosis Study. Body
fat and lean mass were measured using dual energy X-ray absorptiometry; body fat mass was expressed as a
percentage of weight (%BF) and appendicular lean mass was adjusted for height (rALM, kg/m2). Poor physical
performance was assessed using the timed up-&-go (TUG) test. Sarcopenic obesity referred to low-rALM (T-
score<-1), poor physical performance (TUG>10 s) and obesity (%BF >25% for men, >35% for women). Fallers were
identified by self-report as having had at least one fall in the previous 12 mo. Associations between sarcopenic
obesity (and its components) and falls were determined using logistic regression after adjusting for age and sex.
Results: In total, 219 (36.6%) had low-rALM, 205 (34.2%) had poor physical performance, 466 (77.9%) were
obese and 69 (11.5%) had all three thereby meeting our criteria for sarcopenic obesity. There were 170 (28.4%)
fallers; falls were more common for those with sarcopenic obesity than without (28 (40.6%) vs 142 (26.8%);
p=0.017). The likelihood of a fall in association with sarcopenic obesity and its components were: sarcopenic obesity
OR=1.65 (95%CI 0.96-2.85), sarcopenia OR=1.52 (0.93-2.47), poor physical performance and obesity OR=1.74
(1.16-2.61), low-rALM OR=1.41 (0.96-2.06), poor physical performance OR=1.88 (1.26-2.80), obesity OR=0.88
(0.57-1.35).
Conclusion: While obesity per se was not associated with falls, there was an increased risk of falls individuals
with sarcopenic obesity that was of borderline statistical significance and this appears to be largely a consequence
of poor physical performance.
Keywords: Ageing; Falls; Lean mass; Skeletal muscle mass; Muscle
function; Physical performance; Sarcopenia; Sarcopenia obesity
Abbreviations: 
Absorptiometry; EWGSOP: European Working Group on Sarcopenia
in Older People; GOS: Geelong Osteoporosis Study; IQR: Interquartile
Range; NHMRC: National Health and Medical Research Council; OR:
Odds Ratio; rALM: Relative Appendicular Lean Mass; SD: Standard
Deviation; TUG: “Timed up-and-Go” Test; %BF: Body Fat Expressed
as a Percentage of Body Weight
Introduction
Falls among older adults can lead to physical injury, loss of
confidence, hospitalization and sometimes death [1]. Falls are
common in this demographic yet there are environmental factors,
clinical disorders and physiological anomalies that can be addressed to
minimize falls risk. Environmental hazards, poor eyesight and use of
psychotropic medications, antihypertensives, sedatives and diuretics
are examples of risk factors that can be targeted to prevent falls.
Slowing or reversing loss of skeletal muscle mass and function might
also reduce falls vulnerability by mitigating problems with gait and
balance.
Until recently, age-related loss of skeletal muscle mass alone was
known as sarcopenia, but current definitions also include loss of
muscle function [2]. Sarcopenia is characterized by diminished type II
(fast) muscle fibres, a loss of lean mass that compromises protein
synthesis and reduces muscle strength [3,4], and decreased motor
neurons which affects balance [5]. Ageing can also be accompanied by
increased adiposity [6] and, if sarcopenia occurs in the face of obesity,
the condition is known as sarcopenic obesity [7]. Indeed, accumulation
of body fat might aggravate skeletal muscle deterioration by favouring
a pro-inflammatory state, which has a detrimental effect on muscle
metabolism [8]; moreover, fat infiltration into muscle fibers is
associated with a marked reduction in muscle strength [9].
Sarcopenia and its components, including low muscle mass, muscle
weakness and/or poor physical performance, have been implicated in
increased falls risk [10-12] but whether obesity heightens this risk is
not clear. The aim of this study was to examine the association between
falls and sarcopenic obesity, and its components, among elderly
individuals in the population.
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Materials and Methods
Participants
This cross-sectional study involves 598 elderly men (n=353) and
women (n=245) aged 65-98 years who were assessed as part of the
Geelong Osteoporosis Study (GOS). Details of study design,
participation and non-participation have been described elsewhere
[13]. In brief, the GOS is a population-based cohort study of adults
randomly-selected from the Commonwealth electoral rolls for the
Barwon Statistical Division in south-eastern Australia. At baseline,
1540 men and 1494 women were recruited 2001-2006 (with 67%
participation) and 1994-1997 (with 77% participation), respectively.
For this analysis, we focused on data collected at recent follow-up
phases for elderly men (2007-2010) and women (2011-2014). At
follow-up, 598 participants aged 65 years and older provided complete
data required for this analysis. All participants gave written, informed
consent. The Barwon Health Human Research Ethics Committee
approved the study.
Data
Body composition measures were provided by whole body
densitometry using dual energy x-ray absorptiometry (DXA, Lunar
Prodigy-Pro, Madison, WI, USA). The percentage body fat mass (%BF)
was calculated as body fat mass expressed as a percentage of body
weight. Obesity was identified as %BF >25% for men and >35% for
women. Appendicular lean mass, a proxy measure of muscle mass, was
expressed relative to height (rALM, kg/m2) and low rALM was defined
as T-score<-1 [14]. We assessed poor physical performance as an
indicator for low-muscle function, by using the “Timed Up-&-Go”
(TUG) test that measures the time taken to stand from a chair, walk a
measured distance of 3 m, turn around, walk back and sit down again
[15]; TUG>10 s indicated poor physical performance. Body weight and
height were measured to the nearest 0.1 kg and 0.001 m, respectively,
and body mass index (BMI) calculated as weight/height. In this
analysis we have designated individuals with sarcopenic obesity as
those with low-rALM (T-score < -1) and poor physical performance
(TUG>10 s) in combination with high %BF (%BF >25% for men and
>35% for women). Sarcopenia referred to the combination of low-
rALM (T-score < -1) and poor physical performance (TUG>10 s),
while ‘poor physical performance and obesity’ referred to the
combination of poor physical performance (TUG>10 s) and obesity
(%BF >25% for men and >35% for women). Falls during the past 12-
months were self-reported and individuals who reported one or more
falls were classified as fallers.
Statistical analysis
Descriptive statistics are reported as mean (± standard deviation,
SD) for continuous variables that were normally-distributed, median
(interquartile range, IQR) for continuous various with a skewed
distribution and count (percentage, %) for categorical variables.
Differences between the two groups with and without sarcopenic
obesity were assessed by Students t-test or chi-square test (Fisher’s
exact for small counts). Associations between sarcopenic obesity (and
its components) and falls were determined using logistic regression
after adjusting for age and sex. Models were checked for interaction
terms. All statistical analyses were performed using Minitab (version
16; Minitab, State College, PA).
Results
Participant characteristics are shown in Table 1, for the whole group
and according to the presence or absence of sarcopenic obesity.
Compared to individuals without sarcopenic obesity, those with
sarcopenic obesity were on average older, weighed less and had lower
BMI, in addition to having higher %BF, lower rALM and higher TUG
scores. Among the 598 participants, 219 (36.6%) had low-rALM, 205
(34.2%) had poor physical performance, 466 (77.9%) were obese and
69 (11.5%) had all three thereby meeting criteria for sarcopenic obesity
(Figure 1). Five hundred and forty (90.3%) participants had at least one
component that contributed to sarcopenic obesity and only 58 (9.7%)
were healthy.
Variables All Sarcopenic Obesity p
N = 598 Yes (n = 69) No (n = 529)
Male 353 (59.0%) 47 (68.1%) 306 (57.8%) 0.103
Age (yr) 74.5
(69.7-80.4)
82.2
(74.6-86.0)
73.5
(69.1-79.2)
<0.001
Weight (kg) 78.0 (± 14.7) 74.2 (± 11.0) 78.5 (± 15.1) 0.005
Height (m) 1.67 (± 0.09) 1.67 (± 0.09) 1.66 (± 0.09) 0.667
BMI (kg/m2) 28.1 (± 4.7) 26.5 (± 2.1) 28.3 (± 4.9) <0.001
%BF 34.3 (± 9.6) 36.0 (± 7.0) 34.1 (± 9.9) 0.045
rALM (kg/m2) 7.44 (± 1.12) 6.76 (± 0.92) 7.53 (± 1.11) <0.001
TUG (s) 9.4 (8.2-11.3) 12.8 (11.4-16.2) 9.1 (8.0-10.4) <0.001
Faller 170 (28.4%) 28 (40.6%) 142 (26.8%) 0.017
Data are presented as mean (± SD), median (interquartile range) or n (%).
BMI: Body Mass Index; %BF Body Fat Percentage; TUG: Timed Up-&-Go Test
Table 1: Subject characteristics. Data are presented for all and
according to the presence or absence of sarcopenic obesity.
Figure 1: Venn diagram depicting the number of individuals with
each physical attribute that contributes to sarcopenic obesity (low
relative appendicular mass, poor physical performance and
obesity).
There were 170 (28.4%) fallers, and these were more common
among participants with sarcopenic obesity (28 (40.6%) vs 142 (26.8%;
p=0.017), sarcopenia (37 (38.1%) vs 133 (26.6%; p=0.020), combined
poor physical performance and obesity (65 (39.9%) vs 105 (24.1%;
p<0.001) and low-rALM (73 (33.3%) vs 97 (25.6%; p=0.043), whereas
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there was no difference detected between those with and without
obesity (130 (27.9%) vs 40 (30.3%; p=0.6).
In multivariable analyses adjusted for age and sex, sarcopenic
obesity was associated with increased likelihood of a fall (OR 1.65,
95%CI 0.96-2.85, p=0.07) as was sarcopenia (OR 1.52 95%CI
0.93-2.47, p=0.09) and low-rALM (OR 1.41, 95%CI 0.96-2.06, p=0.08),
but these did not achieve statistical significance. Poor physical
performance was associated with a 1.88-fold increase in the likelihood
for falls (OR 1.88, 95%CI 1.26-2.80, p=0.002), and the combination of
poor physical performance and obesity was associated with 1.74-fold
increase (OR 1.74, 95%CI 1.16-2.61, p=0.007), whereas no association
was detected for obesity (OR 0.88, 95%CI 0.57-1.35, p=0.6). No effect
modification was detected in the models.
Discussion
While obesity per se was not associated with falls, individuals with
sarcopenic obesity had an increased risk for falls of borderline
significance and this appears to be largely a consequence of poor
physical performance. Elderly individuals with sarcopenia have limited
mobility and are habitually less active [16] which aggravates muscle
deterioration and promotes weight gain, and this combination impacts
negatively on functional status. Mobility limitations, however, may
limit the exposure to falls risk, possibly explaining our inability to
observe a statistically significant increase.
Sarcopenic obesity has been linked to increased falls risk in some
[9,17] but not all [17,18] studies. A prospective study of older men
enrolled in the Concord Health and Ageing in Men Project in Australia
used recommendations from the European Working Group on
Sarcopenia in Older People (EWGSOP) [2] in combination with %BF
>30 to identify sarcopenic obesity; they reported that compared with
non-sarcopenic non-obese men, those with sarcopenic obesity, non-
sarcopenic obesity and sarcopenic non-obesity all had elevated 2-year
fall rates [17]. In this study, there were no associations detected
between sarcopenic obesity and falls when sarcopenia was defined
according to recommendations by the Foundation for the National
Institutes of Health (FNIH) Sarcopenia Project [19]. This disparity
highlights how different definitions for caseness can affect study
findings and underscores the need for a consensus for defining
sarcopenia and sarcopenic obesity.
Therefore, discrepancies in extant literature are likely driven by
heterogeneous study designs and methodologies. In our study, we
based the definition of sarcopenia on recommendations from
EWGSOP, which considered low muscle mass and low muscle function
[2]. Muscle mass is commonly measured by densitometry or
bioelectric impedance analysis; we utilised DXA-derived rALM and
thresholds from an Australian population [14]. Muscle function can be
assessed via measures of muscle strength and/or physical performance;
we opted to use the TUG test [15] and a threshold of 10s as a marker of
poor physical performance. It should be noted that TUG assesses gait
and balance, and high TUG times have previously been recognized as a
marker of increased falls risk [20]. Furthermore, different definitions
for obesity might involve BMI, waist circumference measures or
assessment of body fat mass. In our study, we selected whole body
DXA-derived %BF because anthropometric measures commonly
underestimate obesity in the elderly [21]. Using these criteria, most
(90.3%) of our study participants had at least one component that
contributed to sarcopenic obesity.
Another study in Australia previously reported that dynapenic
obesity and not sarcopenic obesity is a predictor of falls risk among
middle-aged and older adults [17]. Dynapenia refers to muscle
weakness [3], thus dynapenic obesity was identified for individuals
with low muscle strength in combination with obesity. In this context,
sarcopenia referred to low appendicular lean mass (adjusted for height
and fat mass), and dynapenia referred to poor lower limb strength, so
the findings suggested that concurrent obesity and muscle weakness,
rather than low muscle mass, increased falls risk. As muscle weakness
is an indicator of muscle function, and TUG (a measure of physical
performance) is also an indicator of muscle function, our study
findings broadly support the notion from the previous study, that
muscle function assessment could have utility for predicting falls risk
in older obese individuals.
Conclusion
Our study has several strengths and limitations. Participants were
drawn at random from the general population and were not selected
on the basis of disease. The objective measures of DXA-derived rALM
and body fat mass are particular strengths. We acknowledge that a test
of muscle strength would arguably have been more indicative of
muscle function than the TUG, and we relied on self-reported falls
data to identify fallers. Furthermore, our data were derived from a
follow-up phase and participation bias cannot be excluded. We
adjusted our models for differences in age and sex but, as with all
observational studies, we cannot exclude the possibility of
unrecognized confounding. As most of our participants were elderly
white residents of Australia, the findings may not be applicable to
other populations. It is also difficult to directly compare our findings
with those from other studies, as results are dependent on criteria for
caseness.
Given these limitations, we conclude that individuals with
sarcopenic obesity tended to be at greater risk for falls than their non-
sarcopenic non-obese peers and that this appeared to be driven by
poor physical performance.
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